13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001475373
申报总市值
US$4.6亿
US$4.6亿
36 檔
32.9%
根据最新整理的 13F 季度数据集，Sector Gamma As 于 Q4 2025 结束时的管理资产规模为 US$4.6亿。该机构在本季度申报了 36 档美股持仓，呈现出该时期的主要投资地图。
Sector Gamma As 在 Q4 2025 进行了结构性的板块轮动与仓位换股。在开立 3 个全新仓位及加仓 22 档持股的同时，亦同步清仓 8 档并减仓 10 档标的。
在资产配置集中度方面，Sector Gamma As 的前 5 大核心持股（包含 BMY, MRK, MDT 等）合计占整体申报市值的 32.9%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BMY | Bristol-myers Squibb Co | 股票-医疗保健 | 9.17% | -2.78% | +28.33% | |
| 2 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 8.73% | -1.34% | +12.76% | |
| 3 | MDT | Medtronic plc | 股票-医疗保健 | 5.90% | +0.24% | -11.14% | |
| 4 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 5.86% | -0.01% | +21.64% | |
| 5 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 4.94% | -1.75% | EXIT | |
| 6 | INCY | Incyte CORP | 股票-医疗保健 | 4.93% | -0.26% | +6.66% | |
| 7 | PFE | Pfizer Inc | 股票-医疗保健 | 4.88% | -1.99% | -31.35% | |
| 8 | AMGN | Amgen Inc | 股票-医疗保健 | 4.55% | -1.86% | -0.81% | |
| 9 | BIIB | Biogen Inc | 股票-医疗保健 | 3.43% | -1.36% | +13.25% | |
| 10 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 3.34% | +0.26% | -31.73% | |
| 11 | CVS | Cvs Health CORP | 股票-医疗保健 | 3.21% | +1.19% | +13.70% | |
| 12 | CAH | Cardinal Health Inc | 股票-医疗保健 | 2.90% | -0.64% | +4.05% | |
| 13 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.86% | +3.65% | NEW | |
| 14 | BRKR | Bruker CORP | 股票-医疗保健 | 2.73% | -0.18% | +1.51% | |
| 15 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 2.72% | -0.67% | +16.74% | |
| 16 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 2.69% | +0.46% | +12.88% | |
| 17 | ELV | Elevance Health Inc | 股票-医疗保健 | 2.60% | +0.69% | +238.91% | |
| 18 | CNC | Centene CORP | 股票-医疗保健 | 2.42% | +1.00% | +21.06% | |
| 19 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 2.14% | +0.77% | +2.69% | |
| 20 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.87% | +0.05% | +32.09% | |
| 21 | AVTR | Avantor Inc | 股票-医疗保健 | 1.82% | +0.66% | +45.76% | |
| 22 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 1.64% | +0.56% | +4.04% | |
| 23 | LH | Labcorp Holdings Inc | 股票-医疗保健 | 1.55% | +0.38% | +4.04% | |
| 24 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 1.42% | -1.67% | EXIT | |
| 25 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 1.34% | -0.34% | -0.91% | |
| 26 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 1.26% | +2.13% | NEW | |
| 27 | CRNX | Crinetics Pharmaceuticals In | 股票-其他 | 1.22% | +0.12% | — | |
| 28 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 1.21% | -0.43% | +19.57% | |
| 29 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.15% | +0.66% | -0.91% | |
| 30 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.15% | — | -0.91% | |
| 31 | KURA | Kura Oncology Inc | 股票-其他 | 1.08% | +0.24% | +3.97% | |
| 32 | PTCT | Ptc Therapeutics Inc | 股票-医疗保健 | 1.07% | +0.56% | -47.57% | |
| 33 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.79% | -1.15% | EXIT | |
| 34 | CGON | Cg Oncology Inc | 股票-其他 | 0.49% | — | — | |
| 35 | OGN | Organon & Co | 股票-医疗保健 | 0.49% | +0.27% | -44.82% | |
| 36 | CERT | Certara Inc | 股票-其他 | 0.46% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | BMY | Bristol-myers Squibb Co | +2.7% | +28.33% | 加仓 |
| 2 | MRK | Merck & Co. Inc. | +2% | +12.76% | 加仓 |
| 3 | ELV | Elevance Health Inc | +1.8% | +238.91% | 加仓 |
| 4 | GILD | Gilead Sciences Inc | +0.9% | +19.81% | 加仓 |
| 5 | BDX | Becton Dickinson And Co | +0.8% | +21.64% | 加仓 |
| 6 | BIIB | Biogen Inc | +0.8% | +13.25% | 加仓 |
| 7 | BRKR | Bruker CORP | +0.7% | +1.51% | 加仓 |
| 8 | TMO | Thermo Fisher Scientific Inc | +0.6% | +17.59% | 加仓 |
| 9 | INCY | Incyte CORP | +0.6% | +6.66% | 加仓 |
| 10 | LNTH | Lantheus Holdings Inc | +0.6% | +45.68% | 加仓 |
| 11 | CAH | Cardinal Health Inc | +0.6% | +4.05% | 加仓 |
| 12 | CNC | Centene CORP | +0.5% | +21.06% | 加仓 |
| 13 | TNDM | Tandem Diabetes Care Inc | +0.5% | -0.91% | 减仓 |
| 14 | EW | Edwards Lifesciences CORP | +0.5% | +32.09% | 加仓 |
| 15 | SNDX | Syndax Pharmaceuticals Inc | +0.4% | +19.57% | 加仓 |
| 16 | AVTR | Avantor Inc | +0.3% | +45.76% | 加仓 |
| 17 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +12.88% | 加仓 |
| 18 | CVS | Cvs Health CORP | +0.3% | +13.70% | 加仓 |
| 19 | AMGN | Amgen Inc | +0.3% | -0.81% | 减仓 |
| 20 | KURA | Kura Oncology Inc | +0.1% | +3.97% | 加仓 |
| 21 | GEHC | GE Healthcare Technology | +0.1% | +2.69% | 加仓 |
| 22 | BIO | Bio-rad Laboratories-a | +0.1% | +4.04% | 加仓 |
| 23 | HCA | Hca Healthcare Inc | — | -0.91% | 减仓 |
| 24 | ZBH | Zimmer Biomet Holdings Inc | -0.1% | +16.74% | 加仓 |
| 25 | DXCM | Dexcom Inc | -0.1% | -0.91% | 减仓 |
| 26 | CERT | Certara Inc | -0.2% | — | 不变 |
| 27 | LH | Labcorp Holdings Inc | -0.3% | +4.04% | 加仓 |
| 28 | ASND | Ascendis Pharma A/S | -0.4% | -32.98% | 减仓 |
| 29 | PTCT | Ptc Therapeutics Inc | -0.7% | -47.57% | 减仓 |
| 30 | OGN | Organon & Co | -1% | -44.82% | 减仓 |
| 31 | IONS | Ionis Pharmaceuticals Inc | -1.1% | -31.73% | 减仓 |
| 32 | MDT | Medtronic plc | -1.3% | -11.14% | 减仓 |
| 33 | PFE | Pfizer Inc | -3% | -31.35% | 减仓 |
| 34 | BAX | Baxter International Inc | — | EXIT | 清仓 |
| 35 | VTRS | Viatris Inc | — | EXIT | 清仓 |
| 36 | HUM | Humana Inc | — | EXIT | 清仓 |
| 37 | ELAN | Elanco Animal Health Inc | — | EXIT | 清仓 |
| 38 | REGN | Regeneron Pharmaceuticals | — | NEW | 新建仓 |
| 39 | CRNX | Crinetics Pharmaceuticals In | — | NEW | 新建仓 |
| 40 | ICLR | ICON Public Limited Company | — | EXIT | 清仓 |
| 41 | SOLV | Solventum CORP | — | EXIT | 清仓 |
| 42 | BNTX | Biontech Se-adr | — | EXIT | 清仓 |
| 43 | ACLXGBX | Arcellx Inc | — | EXIT | 清仓 |
| 44 | CGON | Cg Oncology Inc | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Sector Gamma As 在 Q4 2025 季度的美股持仓总市值约为 US$4.6亿，共申报了 36 个公开持股仓位。
在 Q4 2025 季度，Sector Gamma As 按市值排列的前三大核心持股分别为：BMY (9.2%)、MRK (8.7%)、MDT (5.9%)。其中最大持股仓位 BMY 占据整体投资组合约 9.2% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
REGN
市值: US$553.0万
本季最大获利了结 / 清仓标的
BAX
前期市值: US$868.8万
在 Q4 2025 季度中，Sector Gamma As 共进行了 43 项持仓异动，包含新建仓 3 个仓位、加仓 22 个仓位、减仓 10 个仓位以及清仓 8 个仓位。 其中最大新建仓标的为 REGN。 本季清仓仓位包含 BAX。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。